Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INSP Inspire Medical Systems	$95.09 +3.8%	$118.18	$73.92 ▼ $225.00	$2.81B	1.22	682,683 shs	309,129 shs
LIVN LivaNova	$55.68 +5.3%	$46.22	$32.48 ▼ $57.35	$3.04B	0.92	705,878 shs	378,944 shs
TNDM Tandem Diabetes Care	$12.02 +8.8%	$15.76	$9.98 ▼ $47.60	$814.62M	1.46	1.72 million shs	1.42 million shs
WRBY Warby Parker	$27.01 +3.6%	$23.43	$12.69 ▼ $29.73	$2.85B	2.09	2.23 million shs	625,036 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INSP Inspire Medical Systems	-1.38%	+8.37%	-29.10%	-35.94%	-51.02%
LIVN LivaNova	-0.99%	-2.35%	+21.35%	+26.22%	+14.17%
TNDM Tandem Diabetes Care	+3.46%	+3.66%	-27.82%	-46.67%	-74.15%
WRBY Warby Parker	-1.71%	-3.02%	+6.29%	+31.33%	+85.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INSP Inspire Medical Systems	4.9313 of 5 stars	4.3	4.0	4.8	3.9	1.7	1.9
LIVN LivaNova	2.6382 of 5 stars	2.5	3.0	0.0	3.6	1.7	1.3
TNDM Tandem Diabetes Care	4.5442 of 5 stars	4.1	3.0	4.9	2.2	1.7	0.6
WRBY Warby Parker	2.241 of 5 stars	2.3	2.0	0.0	3.5	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INSP Inspire Medical Systems	2.54	Moderate Buy	$165.62	75.28% Upside
LIVN LivaNova	3.00	Buy	$59.71	7.19% Upside
TNDM Tandem Diabetes Care	2.27	Hold	$22.47	87.53% Upside
WRBY Warby Parker	2.58	Moderate Buy	$24.06	-10.60% Downside

Current Analyst Ratings Breakdown

Latest TNDM, LIVN, WRBY, and INSP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	LIVN LivaNova	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$55.00 ➝ $58.00
8/21/2025	TNDM Tandem Diabetes Care	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$10.35 ➝ $11.00
8/15/2025	INSP Inspire Medical Systems	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$116.00 ➝ $97.00
8/11/2025	TNDM Tandem Diabetes Care	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$75.00 ➝ $12.00
8/8/2025	WRBY Warby Parker	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/8/2025	WRBY Warby Parker	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$20.00 ➝ $23.00
8/8/2025	TNDM Tandem Diabetes Care	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$53.00 ➝ $51.00
8/8/2025	WRBY Warby Parker	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$21.00 ➝ $22.00
8/7/2025	WRBY Warby Parker	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive
8/7/2025	TNDM Tandem Diabetes Care	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$59.00 ➝ $24.00
8/7/2025	TNDM Tandem Diabetes Care	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$30.00 ➝ $14.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INSP Inspire Medical Systems	$802.80M	3.48	$1.73 per share	54.46	$22.92 per share	4.12
LIVN LivaNova	$1.25B	2.43	$4.42 per share	12.59	$20.56 per share	2.71
TNDM Tandem Diabetes Care	$940.20M	0.86	N/A	N/A	$1.97 per share	6.08
WRBY Warby Parker	$771.32M	3.67	$0.34 per share	78.24	$3.44 per share	7.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INSP Inspire Medical Systems	$53.51M	$1.73	54.62	29.34	2.90	6.17%	10.38%	8.93%	11/3/2025 (Estimated)
LIVN LivaNova	$63.23M	-$3.89	N/A	17.74	N/A	-16.13%	14.57%	6.91%	10/29/2025 (Estimated)
TNDM Tandem Diabetes Care	-$96.03M	-$3.09	N/A	N/A	N/A	-20.51%	-65.40%	-13.87%	11/5/2025 (Estimated)
WRBY Warby Parker	-$20.39M	-$0.07	N/A	269.17	N/A	-1.12%	-0.79%	-0.41%	11/6/2025 (Estimated)

Latest TNDM, LIVN, WRBY, and INSP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	LIVN LivaNova	$0.84	$1.05	+$0.21	$0.50	$332.20 million	$352.50 million
8/6/2025	Q2 2025	TNDM Tandem Diabetes Care	-$0.40	-$0.48	-$0.08	-$0.78	$238.39 million	$240.68 million
8/4/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	$0.45	+$0.23	-$0.12	$214.50 million	$217.09 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
TNDM Tandem Diabetes Care	N/A	N/A	N/A	N/A	N/A
WRBY Warby Parker	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INSP Inspire Medical Systems	N/A	6.14	4.84
LIVN LivaNova	0.31	1.29	1.09
TNDM Tandem Diabetes Care	2.32	2.44	1.88
WRBY Warby Parker	N/A	2.55	2.23

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INSP Inspire Medical Systems	94.91%
LIVN LivaNova	97.64%
TNDM Tandem Diabetes Care	N/A
WRBY Warby Parker	93.24%

Insider Ownership

Company	Insider Ownership
INSP Inspire Medical Systems	4.10%
LIVN LivaNova	0.29%
TNDM Tandem Diabetes Care	1.90%
WRBY Warby Parker	18.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INSP Inspire Medical Systems	1,246	29.57 million	28.36 million	Optionable
LIVN LivaNova	2,900	54.60 million	54.44 million	Optionable
TNDM Tandem Diabetes Care	2,650	67.57 million	66.29 million	Optionable
WRBY Warby Parker	3,780	105.19 million	86.00 million	Optionable

TNDM, LIVN, WRBY, and INSP Headlines

Recent News About These Companies

Vanguard Group Inc. Has $176.82 Million Holdings in Warby Parker Inc. $WRBY

August 22 at 3:18 AM | marketbeat.com

Northwest & Ethical Investments L.P. Cuts Stake in Warby Parker Inc. $WRBY

August 21 at 4:43 AM | marketbeat.com

Cetera Investment Advisers Makes New $319,000 Investment in Warby Parker Inc. $WRBY

August 21 at 3:08 AM | marketbeat.com

Fox Run Management L.L.C. Makes New $552,000 Investment in Warby Parker Inc. $WRBY

August 20 at 5:11 AM | marketbeat.com

Lord Abbett & CO. LLC Has $6.58 Million Position in Warby Parker Inc. (NYSE:WRBY)

August 19 at 5:17 AM | marketbeat.com

1,675,768 Shares in Warby Parker Inc. (NYSE:WRBY) Purchased by Nuveen LLC

August 19 at 4:21 AM | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Stock Position Decreased by Deutsche Bank AG

August 18, 2025 | marketbeat.com

Aigen Investment Management LP Takes Position in Warby Parker Inc. (NYSE:WRBY)

August 16, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Director Sells $141,360.00 in Stock

August 15, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 50,000 Shares

August 15, 2025 | marketbeat.com

Stocks Showing Market Leadership: Warby Parker Earns 93 RS Rating

August 14, 2025 | msn.com

Warby Parker CFO Steve Miller Resigns

August 14, 2025 | theglobeandmail.com

Telsey Advisory Sticks to Its Buy Rating for Warby Parker (WRBY)

August 14, 2025 | theglobeandmail.com

The 5 Most Interesting Analyst Questions From Warby Parker’s Q2 Earnings Call

August 14, 2025 | finance.yahoo.com

Teresa Briggs Sells 6,000 Shares of Warby Parker Inc. (NYSE:WRBY) Stock

August 14, 2025 | insidertrades.com

Connor Clark & Lunn Investment Management Ltd. Has $5.09 Million Position in Warby Parker Inc. (NYSE:WRBY)

August 14, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Position Trimmed by AIA Group Ltd

August 13, 2025 | marketbeat.com

236,623 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by King Luther Capital Management Corp

August 13, 2025 | marketbeat.com

Warby Parker’s Earnings Call: Growth and Strategic Moves

August 13, 2025 | msn.com

WRBY Q2 Deep Dive: Retail Expansion, AI Partnerships, and Margin Leverage Define the Quarter

August 12, 2025 | msn.com

Warby Parker Inc. (NYSE:WRBY) Shares Sold by Polen Capital Management LLC

August 11, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNDM, LIVN, WRBY, and INSP Company Descriptions

Inspire Medical Systems NYSE:INSP

$95.09 +3.47 (+3.79%)

As of 03:35 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

LivaNova NASDAQ:LIVN

$55.68 +2.82 (+5.33%)

As of 03:35 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Tandem Diabetes Care NASDAQ:TNDM

$12.02 +0.97 (+8.78%)

As of 03:35 PM Eastern

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Warby Parker NYSE:WRBY

$27.01 +0.94 (+3.61%)

As of 03:35 PM Eastern

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time